1. Home
  2. BZH vs APLT Comparison

BZH vs APLT Comparison

Compare BZH & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beazer Homes USA Inc.

BZH

Beazer Homes USA Inc.

HOLD

Current Price

$23.18

Market Cap

672.0M

ML Signal

HOLD

Logo Applied Therapeutics Inc.

APLT

Applied Therapeutics Inc.

HOLD

Current Price

$0.10

Market Cap

18.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZH
APLT
Founded
1985
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
672.0M
18.0M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
BZH
APLT
Price
$23.18
$0.10
Analyst Decision
Strong Buy
Hold
Analyst Count
3
2
Target Price
$32.00
$1.25
AVG Volume (30 Days)
408.6K
11.6M
Earning Date
01-29-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.52
N/A
Revenue
$2,371,555,000.00
$1,000,000.00
Revenue This Year
$7.40
$124.18
Revenue Next Year
$12.09
$25.00
P/E Ratio
$15.64
N/A
Revenue Growth
1.77
N/A
52 Week Low
$17.37
$0.09
52 Week High
$29.30
$1.50

Technical Indicators

Market Signals
Indicator
BZH
APLT
Relative Strength Index (RSI) 61.62 30.38
Support Level $23.52 $0.10
Resistance Level $24.52 $0.10
Average True Range (ATR) 0.83 0.01
MACD 0.36 0.02
Stochastic Oscillator 76.40 60.00

Price Performance

Historical Comparison
BZH
APLT

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: